Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Site

Explore clinical trials studying Neoplasms by Site. Study availability and eligibility vary by location and protocol.

50,540 public trials 10,738 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Site trial results

Recruiting

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

NCT07569926

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of California San Diego Health San Diego, California, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Recruiting

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

NCT07020117

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
Locations
  • City of Hope Duarte, California, United States
  • Hoag Memorial Hospital Presbyterian Irvine, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Advent Health Medical Group Radiation Oncology at Central Florida Orlando, Florida, United States
View all 13 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

NCT07221149

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations
  • Local Institution - 0284 Phoenix, Arizona, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center Orange, California, United States
  • Local Institution - 0428 San Francisco, California, United States
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
View all 161 locations
View Trial Details
Recruiting

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

NCT07405801

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Avera Cancer Institute - Marshall Marshall, Minnesota, United States
  • Avera Cancer Institute - Aberdeen Aberdeen, South Dakota, United States
  • Avera Cancer Institute - Mitchell Mitchell, South Dakota, United States
  • Avera Cancer Institute - Pierre, SD Pierre, South Dakota, United States
View all 58 locations
View Trial Details
Recruiting

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

NCT06725693

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +13 more
Locations
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

NCT07659795

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START New Jersey East Brunswick, New Jersey, United States
View all 14 locations
View Trial Details

Related conditions